Browse > Article

Pharmacokinetic Study of Promethazine in Korean Healthy Subjects Using a Validated HPLC Method  

Jang, Jung-Ok (College of Pharmacy, Ewha Womans University)
Go, Eun-Jung (College of Pharmacy, Ewha Womans University)
Kim, Na-Hyung (College of Pharmacy, Ewha Womans University)
Chung, Soo-Yeon (College of Pharmacy, Ewha Womans University)
Park, Hyo-Min (College of Pharmacy, Ewha Womans University)
Lee, Hwa-Jeong (College of Pharmacy, Ewha Womans University)
Publication Information
Biomolecules & Therapeutics / v.13, no.2, 2005 , pp. 118-122 More about this Journal
Abstract
The objective of the present investigation was to study pharmacokinetics of promethazine in Korean healthy subjects using a validated HPLC method. The HPLC analysis was performed on a Capcell Pak CN column with a mixture of acetonitrile-0.02M potassium dihydrogen phosphate (42:58, v/v, pH 6.0) and the analyte was quantified with UV detection at 251 nm. The calibration curve of the drug was linear over the range of 1-40ng/mL in human serum and the limit of quantification (LOQ) was 1 ng/mL. This analytical method was validated and shown to be specific, accurate, precise and reproducible. This method was applied to pharmacokinetic study of promethazine in Korean healthy volunteers following an oral administration of two 25 mg Himazin tablets (50 mg promethazine ${\cdot}$HCI) after overnight fasting. Serum samples were collected at given intervals over a 36-hour period (12 points) and pharmacokinetic parameters were determined from serum concentration-time profile using WinNonlin program. The estimated $AUC_{0__\infty}$, $AUC_{0_\infty}$, $C_{max}$, $T_{max}$ and $t_{1/2}$ of promethazine obtained from Korean healthy subjects were 103.84 ${\pm}$84.30 ng${\cdot}$hr/mL, 87.94${\pm}$81.02 ng${\cdot}$hr/mL, 13.43${\pm}$10.92 ng/mL, 2.00${\pm}$1.16 hr and 5.88${\pm}$3.47 hr, respectively.
Keywords
Promethazine; HPLC; human serum; pharmacokinetic study; validation;
Citations & Related Records
연도 인용수 순위
  • Reference
1 DiGregorio G. J. and Ruch E. (1980) Human whole blood and parotid saliva concentrations of oral and intramuscular promethazine. J Pharm. Sci. 69, 1457-1459   DOI
2 Fox, A.R. and McLoughlin D. A. (1993) Rapid, sensitive high-performance liquid chromatographic method for the quantification of promethazine in human serum with electrochemical detection. J Chromatogr. 631, 255-259   DOI   ScienceOn
3 Vanapalli, S. R., Kambhampati, S. P., Putcha, L. and Bourne, D. W. A. (2001). A liquid chromatographic method for the simultaneous determination of promethazine and three of its metabolites in plasma using electrochemical and UV detectors. J Chromatogr. Sci., 39, 70-72   DOI   ScienceOn
4 Wallace, J. E., Shimek, E. Jr., Stavchansky, S. and Harris, S. C. (1981). Determination of promethazine and other phenothiazine compounds by liquid chromatography with electrochemical detection. Anal. Chem. 53, 960-962   DOI   ScienceOn
5 Stavchansky, S., Wallace, J. E., Geary, R., Hecht, G.., Robb, C. A. and Wu, P. (1987). Bioequivalence and phannacokinetic profile of promethazine hydrochloride suppositories in humans. J Pharm. Sci. 76, 441-445   DOI
6 Lackner, J. R. and Graybiel, A. (1994). Use of promethazine to hasten adaptation to provocative motion. J Clin. Pharmacal. 34, 644-648   DOI   ScienceOn
7 Pistos, C. and Stewart, J. T. (2003). Direct injection HPLC method for the determination of selected phenothiazines in plasma using a Hisep column. Biomed. Chromatogr. 17, 465-470   DOI   ScienceOn
8 Quinn J. and Calvert R. (1976). The disposition of promethazine in man [proceedings]. J Pharm. Pharmacol. 28, suppl-59
9 Schwinghammer, T. L., Juhl, R. P., Dittert, L. W., Melethil, S. K., Kroboth, F. J. and Chung, V.S. (1984). Comparison of the bioavailability of oral, rectal and intramuscular promethazine. Biopharm. Drug Dispos. 5, 185-194   DOI   ScienceOn
10 Song, Q. and Putcha, L. (2001) Quantitation of promethazine and metabolites in urine samples using on-line solid-phase extraction and column-switching. J Chromatogr. B. 763, 920
11 Strenkoski-Nix, L.C., Ermer, J., DeCleene, S., Cevallos, W. and Mayer, P.R. (2000). Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects. Am. J Health-Syst. Pharm. 57, 1499-1505
12 Taylor, G.., Houston, J. B., Shaffer J. and Mawer, G. (1983). Pharmacokinetics of promethazine and its sulphoxide metabolite after intravenous and oral administration to man. Br. J Clin. Pharmacol. 15, 287-293   DOI   ScienceOn
13 Temdrup, T. E., Dire, D. J., Madden. C. M., Davis, H., Cantor, R. M. and Gavula, D. P. (1991). A prospective analysis of intramuscular meperidine, promethazine, and chlorpromazine in pediatric emergency department patients. Ann. Emerg. Med. 20, 31-35   DOI   ScienceOn
14 Bagli, M., Rao, M. L., Hoflich, G. (1994) Quantification of chlorprothixene, levomepromazine and promethazine in human serum using high-performance liquid chromatography with coulometric electrochemical detection. J Chromatogr. B Biomed. Appl. 657, 141-148   DOI   ScienceOn
15 Zaman, R., Honigberg, I. L., Francisco, G. E., Kotzan J. A., Stewart, J. T., Brown W. J., Shah. V. P. and Pelsor, F. R. (1986). Bioequivalency and dose proportionality of three tableted promethazine products. Biopharm. Drug Dispos. 7, 281-291   DOI   ScienceOn
16 Tarkkila, P., Tom, K., Tuominen, M. and Lindgren, L. (1995). Premedication with promethazine and transdermal scopolamine reduces the incidence of nausea and vomiting after intrathecal morphine. Acta Anaesthesiol. Scand. 39, 983-986   DOI   ScienceOn